A retrospective study to analyze Treatment patterns, time and type of biomarker testing, and overall survival (OS) inALK inhibitor-treated patients
Latest Information Update: 19 Feb 2020
At a glance
- Drugs Ceritinib (Primary) ; Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 19 Feb 2020 New trial record